Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$GILD Q3 '25 Earnings Results & Recap Gilead's Q3 2025 earnings beat EPS estimates at $2.47 (or $2.22 excluding a one-time item), and revenue was $7.3 billion, slightly below the $7.45B estimate; the company is increasing its full-year HIV revenue growth expectations to approximately 5%, while forecasting cell therapy to decline approximately 10% for the full year.

Since Post

Full Details

Advertisement|Remove ads.